Recent patents on mesenchymal stem cell mediated therapy in inflammatory diseases

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 7, Issue 2, 2013, Pages 105-113

  Nair, Meera ^a   Saxena, Pooja ^a  

^a PEOPLE S COLLEGE OF DENTAL SCIENCES AND RESEARCH CENTRE   (India)

Author keywords

Anti inflammatory; Autoimmune disorders; Immunemodulators; Mesenchymal stem cells (MSCs); Stem cells; Umbilical cord derived mesenchymal stem cells

Indexed keywords

PROGRAMMED DEATH 1 RECEPTOR; REMESTEMCEL L;

ACUTE LUNG INJURY; ADIPOSE DERIVED STEM CELL; ADULT RESPIRATORY DISTRESS SYNDROME; ADULT STEM CELL; ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CELL ISOLATION; CRITICAL LIMB ISCHEMIA; CROHN DISEASE; DENDRITIC CELL; DISCOGENIC PAIN; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOMODULATION; INFLAMMATORY DISEASE; KNEE OSTEOARTHRITIS; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MULTIPLE SCLEROSIS; NONHUMAN; PATENT; PLURIPOTENT STEM CELL; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; STEM CELL RESEARCH; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRAUMATIC BRAIN INJURY;

ANIMALS; HUMANS; INFLAMMATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PATENTS AS TOPIC; REGENERATIVE MEDICINE;

EID: 84878637984     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1872213X11307020002     Document Type: Review

References (79)

1. Barry FP, Murphy JM. Mesenchymal stem cells: Clinical applica tions and biological characterization. Int J Biochem Cell Biol 2004; 36(4):568-84.
2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126(4):663-76.
3. The Nobel Prize in Physiology or Medicine 2012: Sir John B. Gur-don, Shinya Yamanaka. Available at: http://www.nobelprize.org/ nobel_prizes/medicine/laureates/2012/ (Accessed on: January 12, 2013).
4. Bianco P, Gehron Robey P. Marrow stromal stem cells. J Clin Invest 2000; 105:1663-8.
5. Tokcaer-Keskin Z, Akar AR, Ayaloglu-Butun F, Terzioglu-Kara E, Durdu S, Ozyurda U, et al. Timing of induction of cardiomyocyte differentiation for in vitro cultured mesenchymal stem cells: A perspective for emergencies. Can J Physiol Pharmacol 2009; 87(2):143-150.
6. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesen-chymal stem cells. Science 1999; 284(5411):143-7.
7. Beyer Nardi N, da Silva Meirelles L. Mesenchymal stem cells: Isolation, in vitro expansion and characterization. Handb Exp Pharmacol 2006; (174):249-82.
8. Murphy JM, Dixon K, Beck S, Fabian D, Feldman A, Barry F. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 2002; 46:704-13.
9. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999; 14(7):1115-22
10. Soleimani M, Nadri S. A protocol for isolation and culture of Mes-enchymal stem cells from mouse bone marrow. Nat Protoc 2009; 4(1):102-6.
11. Phinney DG, Kopen G, Isaacson RL, Prockop DJ. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: Variations in yield, growth and differentiation. J Cell Biochem 1999; 72(4):570-85.
12. Sun S, Guo Z, Xiao X, Liu B, Liu X, Tang PH, et al. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cells 2003; 21:527-35.
13. Friedenstein AJ. Stromal mechanisms of bone marrow: Cloning in vitro and re-transplantation in vivo. Haematol Blood Trans-fus 1980; 25:19-29.
14. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, et al. Characterization of human bone marrow fi-broblast colony-forming cells (CFU-F) and their progeny. Blood 1980; 56(2):289-301.
15. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991; 78(1):55-62.
16. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000; 6:1282-86.
17. Newman RE, Yoo D, LeRoux MA, Danilkovitch-Miagkova A. Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets 2009; 8(2):110-23.
18. Salas A, Ricart E, Panés J. Cell therapies for inflammatory bowel diseases. Expert Rev Gastroenterol Hepatol 2009; 3(4):321-4.
19. Gonzalez-Rey E, Anderson P, González MA, Rico L, Büscher D, Delgado M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 2009; 58(7):929-39.
20. Secco M, Zucconi E, Vieira NM, Fogaca LL, Cerqueira A, Carva-lho MD, et al. Multipotent stem cells from umbilical cord: Cord is richer than blood. Stem Cells 2008; 26(1):146-50.
21. Baksh D, Yao R, Tuan RS. Comparison of proliferative and multi-lineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007; 25(6):1384-92.
22. Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 2010; 62(8):2467-75.
23. Liang L, Dong C, Chen X, Fang Z, Xu J, Liu M, et al. Human umbilical cord mesenchymal stem cells ameliorate mice trinitro-benzene sulfonic acid (TNBS)-induced colitis. Cell Transplant 2011; 20(9):1395-08.
24. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, IIancheran S, et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomicin-induced lung injury. Am J Pathol 2009; 175(1):303-13.
25. Liu Y, Mu R, Wang S, Long L, Liu X, Li R, et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther 2010; 12(6):R210.
26. Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation. Mol Ther 2012; 20(1):14-20.
27. Galindo LT, Filippo TR, Semedo P, Ariza CB, Moreira CM, Camara NO, et al. Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury. Neurol Res Int 2011; 564089.
28. Salem HK, Thiemermann C. Mesenchymal stromal cells: Current understanding and clinical status. Stem Cells 2010; 28(3):585-96.
29. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7(9):678-89.
30. Maitra B, Szekely E, Gjini K, Laughlin MJ, Dennis J, Haynesworth SE, et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 2004; 33(6):597-604.
31. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105(4):1815-22.
32. Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, et al. Human Mesenchymal stem cells alter antigen presenting cell maturation and induce T-cell unresponsiveness. Blood 2005; 105(5):2214-9.
33. Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G. Cell therapy using allogeneic bone marrow Mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthrithis Rheum 2007; 56(4):1175-86.
34. Bunnell BA, Betancourt AM, Sullivan DE. New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Res Ther 2010; 1(5):34.
35. Iyer SS, Rojas M. Anti-inflammatory effects of mesenchymal stem cells: Novel concept for future therapies. Expert Opin Biol Ther 2008; 8(5):569-81.
36. Rasmusson I, Uhlin M, Le Blanc K, Levitsky V. Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes. J Leukoc Biol 2007; 82(4):887-93.
37. Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J. Alloge-neic marrow stromal cells are immune rejected by MHC class I-and class II- mismatched recipient mice. Blood 2005; 106(13):4057-65.
38. Li J, Li D, Liu X, Tang S, Wei F. Human umbilical cord mesen-chymal stem cells reduce systemic inflammation and attenuate LPS-induced acute lung injury in rats. J Inflamm 2012; 9(1):33.
39. Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, Pedemonte E, et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encepalomyelitis. Ann Neurol 2007; 61(3):219-27.
40. Choi JJ, Yoo SA, Park SJ, Kang YJ, Kim WU, Oh IH, et al. Mes-enchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin Exp Immunol 2008; 153(2):269-76.
41. Urbán VS, Kiss J, Kovács J, Gócza E, Vas V, Monostori E, et al. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 2008; 26(1):244-53.
42. Swenson E, Theise N. Stem cell therapeutics: Potential in the treatment of inflammatory bowel disease. Clin Exp Gastroen-terol 2010; 3:1-10.
43. Bouffi C, Bony C, Courties G, Jorgensen C, Noël D. IL-6-dependent PGE-2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One 2010; 5(12):e14247.
44. Norambuena GA, Khoury M, Jorgensen C. Mesenchymal stem cells in osteoarticular pediatric diseases: An update. Pediatr Res 2012; (4 Pt 2):452-8.
45. Pandey AC, Dutreil MF, Phinney DG. Anti-inflammatory properties of murine mesenchymal stem Cells: Role of interleukin 1 receptor antagonist. FASEB J 2008; 22:1197.5.
46. Wise AF, Ricardo SD. Mesenchymal stem cells in kidney inflammation and repair. Nephrology (Carlton) 2012; 17(1):1-10.
47. Caplan AI. Why are MSCs therapeutic? New data: New insight. J Pathol 2009; 217(2):318-24.
48. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 2007; 104(26):11002-7.
49. Semedo P, Palasio CG, Oliveira CD, Feitoza CQ, Gonçalves GM, Cenedeze MA, et al. Early modulation of inflammation by Mesenchymal stem cells after acute kidney injury. Int Immuno-pharamcol 2009; 9(6):677-82.
50. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop J. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation and differentiation potential. Blood 2004; 103(5):1662-8.
51. Porada CD, Almeida-Porada G. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev 2010; 62(12):1156-66.
52. Menon LG, Kelly K, Yang HW, Kim SK, Black PM, Carroll RS. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells 2009; 27(9):2320-30.
53. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (Prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009; 54(24):2277-86.
54. Mesenchymal stem cell therapy in inflammation. Available at: http://www.clinicaltrials.gov/ct2/results?term=Mesenchymal+stem+cell+therapy+in+inflammation&Search=Search. (Accessed on: February 22, 2013).
55. Delgardo, M., Gonzalez-Rey, E., Büscher, D. Uses of mesenchy-mal stem cells. US20120027730 (2012).
56. Mannon PJ. Remestemcel L. Human mesenchymal stem cells as an emerging therapy for Crohn's disease. Expert Opin Biol Ther 2011; 11(9):1249-56.
57. Harman, J.R., Sand, T.T. Methods of preparing and using stem cell compositions and kits comprising the same. EP1678295 (2004).
58. Dzau, V.J., Mangi, A., Ip, J.E. Mesenchymal stem cells and uses therefore. US20040258669 (2004).
59. Westenfelder, C. Therapy of kidney diseases and multiorgan failure with mesenchymal stem cells and mesenchymal stem cell conditioned media. US20080241112 (2008).
60. Aggarwal, S., Pittenger, F.M. Mesenchymal stem cells and uses therefor. EP1727892 (2008).
61. Foussat, A., Belmonte, N. Tr1 cells, mesenchymal stem cells and uses thereof. EP20100247577 (2010).
62. Prockop, D.J., Lee, R.H. Mesenchymal stem cells, compositions and methods for treatment of cardiac tissue damage. US2009003657 (2010).
63. Büscher, D., Delgado, M., Gonzalez-Rey, E. Uses of Mesenchymal stem cells. EP2328594 (2011).
64. Dennis, J.E., Kean, T.J. Compositions and Methods of Treating Inflammation. US20120141564 (2012).
65. Fisk, M.N., Wolvetang, J.E., Pelekanos, R.A. Method for stem cell differentiation. EP2529009 (2012).
66. Burkly, L. Methods for pancreatic tissue regeneration. US20120020913 (2012).
67. Dzau, V., Mirotsou, M. Stem cell derived paracrine factor SFRP2 for use in reducing cell death associated with myocardial infarction. EP2226079 (2012).
68. Nelson, P. Engineered mesenchymal stem cells and method of using same to treat tumors. EP2419113 (2012).
69. Lim, S.K., Tan, K.H. Pre-natal mesenchymal stem cells. EP2456861 (2012).
70. Cool, S.M., Nurcombe, V. Methods of culturing mesenchymal stem cells. US8287853 (2012).
71. Gordon, S.L., Mackay, A.M., Martin, B.J., Pittenger, M.F. Cardiac muscle regeneration using mesenchymal stem cells. US20120213749 (2012).
72. Hashi, K., Honmou, O., Uede, T. Mesenchymal stem cell and the method of use thereof. US20120230961 (2012).
73. Tsuchiya, T., Tsuji, K., Kato, Y., Shao, J.C., Hara, M. Cell preparation containing Mesenchymal stem cells and method for producing same. US20120329087 (2012).
74. Bartosh Jr, T.W., Prockop, D.J., Ylostalo, J. Spheroidal aggregates of mesenchymal stem cells. US20120219572 (2012).
75. Song, L., Long, M. Primed stem cells and uses thereof to treat inflammatory conditions in joints. US20120328578 (2012).
76. Lee, T. Stem-cell material and method of use. US20130058903 (2013).
77. Mar, K., Ma, C.M., Chu, R.-M. Method of implanting Mesenchy-mal stem cells for natural tooth regeneration in surgically prepared extraction socket and compositions thereof. US20130029292 (2013).
78. Raghunath, M., Loe, H.L., Blocki, A. Culture additives to boost stem cell proliferation and differentiation response. EP2542666 (2013).
79. Mistry, S. A cellular therapy for ocular degeneration. EP1888123 (2013).